Literature DB >> 10360770

Corticostriatal plasticity is restricted by myelin-associated neurite growth inhibitors in the adult rat.

G L Kartje1, M K Schulz, A Lopez-Yunez, L Schnell, M E Schwab.   

Abstract

After unilateral cortical lesions in neonatal rats, the spared unablated hemisphere is known to demonstrate remarkable neuroanatomical plasticity in corticofugal connectivity. This same type of structural plasticity is not seen after similar lesions in adult rats. One possibility for the lack of such a plastic response in the adult central nervous system may be the presence of myelin-associated neurite growth inhibitory proteins NI-35/NI-250. These proteins have previously been found to play a crucial role in preventing axotomized fibers from regenerating after adult rat spinal cord lesions. The aim of this study was to determine if blocking these inhibitory proteins by the application of the specific monoclonal antibody IN-1 would enhance corticostriatal plasticity from the spared hemisphere after unilateral cortical lesions in adult rats. Six- to 8-week-old Lewis rats underwent unilateral aspiration lesion of the sensorimotor cortex. Animals were immediately treated with either monoclonal antibody IN-1 or a control antibody released from hybridoma cells in Millipore filter capsules. After a survival period of 12 weeks, the opposite sensorimotor cortex was stereotaxically injected with the anterograde tracer biotinylated dextran amine, and biotinylated dextran amine-positive corticostriatal fibers were analyzed. The monoclonal antibody IN-1-treated animals showed an increase in corticostriatal fibers in the dorsolateral striatum contralateral to the injection site compared with control antibody-treated animals or normal controls, indicating a specific sprouting response in the deafferented zone. These results support the idea that through blockade of myelin-associated neurite inhibitory proteins, lesion-induced corticofugal plasticity is possible even in the adult central nervous system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360770     DOI: 10.1002/1531-8249(199906)45:6<778::aid-ana12>3.0.co;2-b

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Nogo-A inhibition induces recovery from neglect in rats.

Authors:  Miranda M Brenneman; Steven J Wagner; Joseph L Cheatwood; Scott A Heldt; James V Corwin; Roger L Reep; Gwendolyn L Kartje; Anis K Mir; Martin E Schwab
Journal:  Behav Brain Res       Date:  2007-09-20       Impact factor: 3.332

2.  Brain fiber tract plasticity in experimental spinal cord injury: diffusion tensor imaging.

Authors:  Jaivijay Ramu; Juan Herrera; Raymond Grill; Tobias Bockhorst; Ponnada Narayana
Journal:  Exp Neurol       Date:  2008-04-03       Impact factor: 5.330

3.  Delayed anti-nogo-a therapy improves function after chronic stroke in adult rats.

Authors:  Shih-Yen Tsai; Catherine M Papadopoulos; Martin E Schwab; Gwendolyn L Kartje
Journal:  Stroke       Date:  2010-11-18       Impact factor: 7.914

4.  Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.

Authors:  Shih-Yen Tsai; Tiffanie M Markus; Ellen M Andrews; Joseph L Cheatwood; April J Emerick; Anis K Mir; Martin E Schwab; Gwendolyn L Kartje
Journal:  Exp Brain Res       Date:  2007-08-24       Impact factor: 1.972

5.  Quantification of synaptic density in corticostriatal projections from rat medial agranular cortex.

Authors:  Roger L Reep; Jennifer H Wu; Joseph L Cheatwood; James V Corwin; Gwendolyn L Kartje; Anis Mir
Journal:  Brain Res       Date:  2008-07-26       Impact factor: 3.252

Review 6.  Therapeutics targeting Nogo-A hold promise for stroke restoration.

Authors:  Prateek Kumar; Lawrence D F Moon
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

7.  Nogo-A expression after focal ischemic stroke in the adult rat.

Authors:  Joseph L Cheatwood; April J Emerick; Martin E Schwab; Gwendolyn L Kartje
Journal:  Stroke       Date:  2008-05-08       Impact factor: 7.914

8.  Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression.

Authors:  Niklas Marklund; Florence M Bareyre; Nicolas C Royo; Hilaire J Thompson; Anis K Mir; M Sean Grady; Martin E Schwab; Tracy K McIntosh
Journal:  J Neurosurg       Date:  2007-10       Impact factor: 5.115

9.  Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain.

Authors:  Robert H Andres; Nobutaka Horie; William Slikker; Hadar Keren-Gill; Ke Zhan; Guohua Sun; Nathan C Manley; Marta P Pereira; Lamiya A Sheikh; Erin L McMillan; Bruce T Schaar; Clive N Svendsen; Tonya M Bliss; Gary K Steinberg
Journal:  Brain       Date:  2011-06       Impact factor: 13.501

10.  Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin.

Authors:  G Onose; D F Mureşanu; A V Ciurea; C Daia Chendreanu; A S Mihaescu; D C Mardare; I Andone; A Spânu; C Popescu; A Dumitrescu; M Popescu; V Grigorean; B Ungur; F Marinescu; I Colibbeanu; L Onose; M Haras; A Sandu; T Spircu
Journal:  J Med Life       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.